Erin Burns, PhD

The COVID-19 pandemic has added another burden, with growing evidence of its negative effects on the well-being of many cancer care providers.

Financial issues are among the top concerns burdening patients with cancer.

The Lung Cancer Screening Implementation Guide was a product of collaboration among 25 experts from 16 institutions. But it was also a product of both the successes and failures of lung cancer screening programs before it.

Through detailing past programs and discussing how they've each addressed their own challenges, the American Thoracic Society and the American Lung Association's new lung cancer screening guide can help clinicians design, implement, conduct, and streamline lung cancer screening programs.

For clinicians who see patients at risk of developing lung cancer, a new guide on the implementation of lung cancer screening programs has been developed by a panel of experts from the American Lung Association and the American Thoracic Society.

Based on the crucial role of BCL-2 family proteins in apoptosis regulation, targeting these proteins using BCL-2 inhibitors offers a potentially new therapeutic option for patients with various types of hematologic malignancies and, more recently, patients with solid tumors.